Abstract
Host innate immune cells, including alveolar macrophages, have been identified as key players in the early eradication of Mycobacterium tuberculosis and in the maintenance of an anti-mycobacterial immune memory, which is believed to be induced through epigenetic changes. The aim of the study was to elucidate whether exposure to M. tuberculosis induced a different DNA methylation pattern of alveolar macrophages and pulmonary T lymphocytes.
Alveolar macrophages and T lymphocytes were isolated from induced sputum obtained from individuals living in Lima, which is an area high endemic for tuberculosis. To determine the latent tuberculosis infection status of the subjects, an interferon-γ release assay was performed. We evaluated the DNA methylomes of the alveolar macrophages and T lymphocytes using the Illumina Infinium Human Methylation 450K Bead Chip array, revealing a distinct DNA methylation pattern in alveolar macrophages allowing the discrimination of asymptomatic individuals with latent tuberculosis infection from non-infected individuals. Pathway analysis revealed that cell signalling of inflammation and chemokines in alveolar macrophages play a role in latent tuberculosis infection. In conclusion, we demonstrated that DNA methylation in alveolar macrophages can be used to determine the tuberculosis infection status of individuals in a high endemic setting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We owe our thanks to the Bioinformatics and Expression Analysis core facility (BEA), which is supported by the board of research at the Karolinska Institute and the research committee at the Karolinska hospital. The study was funded through a grant from the Swedsih Research Council # 2018-04246 and the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica CONCYTEC and Cienciactiva (No 106-2018-FONDECYT). The computations & data handling were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at National Supercomputing Centre (NSC), Linkoping University partially funded by the Swedish Research Council through grant agreement No 2018-05973 and the support by grants from the World Infection Fund. J.D is a postdoctoral fellow supported through the Medical Infection and Inflammation Center (MIIC) at Linkoping University. We direct our gratitude to all the subjects for donating samples. We are also grateful for the help of Ronald Cadillo Hernandez and Rodrigo Cachay Figueroa.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Institutional Committee on Research Ethics Comite Institucional de Etica en Investigacion (CIEI) of the Cayetano Heredia National Hospital, No 082-018 for the inclusion of patients and Universidad Peruana Cayetano Heredia Institutional Review Board No 101773 for the inclusion of healthy subjects.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Sequencing datasets will be made publicly available upon acceptance and prior to final publication.
